TECIL Chemical (TECILCHEM)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 47.71% shows significant insider skin in the game.
• Latest quarter net loss is only ₹-0 Cr, indicating no major visible cash burn.
• Market cap of ₹26 Cr leaves room for an outsized stock move if a genuine turnaround emerges.
• Reported ROE is positive at 2.01%, suggesting some residual equity earnings power.

Concerns

• Latest quarter sales are ₹0 Cr and net profit is ₹-0 Cr, so there is no visible operating business.
• Piotroski F-Score of 2/9 signals weak financial health.
• ROCE is 0.00% and profit growth is -16.67%, meaning capital is earning no return and earnings are deteriorating.
• Book value and debt/equity are N/A, so downside and leverage cannot be assessed.

AI Analysis

Let me start with the simplest test: can this company earn a decent return on the capital entrusted to it? The record says no. Latest quarter sales are ₹0 Cr, net profit is ₹-0 Cr, ROCE is 0.00%, and profit growth is down 16.67%. A business that generates no revenue and no profit is not earning its keep. The market price of ₹14.10 gives a market cap of ₹26 Cr, but with P/E of 0.00 and book value unavailable, there is no earnings yield and no liquidation anchor to hang a valuation on. Graham taught me to buy a dollar for forty cents, but I cannot even calculate the dollar here. The Piotroski F-score of 2 out of 9 only confirms distress; this is a financially weak company by almost every operational test. Promoter holding of 47.71% is good to see, because insiders have skin in the game, but ownership alone does not create value. In commodity chemicals, where product is undifferentiated, the only moats are scale, cost, and customer relationships. This company shows no sales, so it has no demonstrated competitive position. ROE of 2.01% is far below a threshold that would compensate for risk. A 52-week range of ₹8.30 to ₹22.87 tells me the stock has traded like a lottery ticket, not like a steady compounder. As investors, we do not need to act on every ticker. When the figures are insufficient, the intelligent thing is to wait. I would need to see actual sales, a positive net profit, and a clean balance sheet before I would look any further. Until then, this is not an investment; it is a speculation on a revival that has yet to appear.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer